ÐÏࡱá>þÿ 02þÿÿÿ/ÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿì¥Á€ ð¿¦bjbjT~T~ 466¦ ÿÿÿÿÿÿ·Ü Ü ÿÿÿÿ3333 ?3XŠSSSSS...ûýýýýýý⢄BýÏ..ÏÏýSSÛÏ.SSûÏûSÿÿÿÿà/ ½3MË3ý ç(0XÆ ÆÆÌ.Lz6°,Üó...ýý ...XÏÏÏÏÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÆ.........Ü å: MEDICAL BIOTECHNOLOGY (WITH BIO-BUSINESS) (MSc/PgDip/PgCert) 57C560B1/61C5MBVX/62C5MBVZ Qualifications for entry: A degree or equivalent qualification, at the prescribed standard, in a relevant biological subject or other relevant discipline. Duration: 12 months full-time or 24 months part time (MSc); 9 months full-time (PgDip) Content: This course has been specifically designed to recognise the commercial maturating of medical biotechnology in Europe and the US, whilst at the same time acknowledging the rapid growth in biotechnological science in many other parts of the world. The course provides a fusion of modules covering many of the latest scientific developments in drug discovery, therapeutics and disease prevention, together with an introduction to the commercial, legal (intellectual property) and ethical aspects of today’s bio-business world. This postgraduate course will provide a unique opportunity to gain experience of the latest science and business developments in the fast moving world of medical biotechnology. For the students embarking on this course, significant emphasis will be placed on self-directed learning allied to a tutorial programme. Candidates shall be required to attend the following designated courses: First Half-Session BT 5009 Immunology: Back to Basics (0 credit points) BT 5010 Small Molecular Drug Discovery (25 credit points) BT 5011 Introduction to Bio-Business and the Commercialisation of Bioscience Research (10 credit points) MB 5015 Molecular Biology Basics & Cloning Lab (15 credit points) MB 5016 Advanced Molecular and Functional Genomics (15 credit points) GS 50M1 Generic Skills Module (0 credit points) SK 5003 Information Skills (0 credit points) Second Half-Session BT 5502 Special study module 2: Biologics (focus on large molecular weight molecules such as peptides and proteins) the next generation of therapeutic agents (25 credit points) BT 5503 Laboratory Techniques – core practical skills (10 credit points) BT 5508 Advanced Bio-Business and Commercialisation of Bioscience Research (15 credit points) Elective BT 5506 Business of Science (5 credit points) MT 55EP Careers & Employability for Postgraduates (5 credit points) BT 5703 Research Project (60 credit points) [MSc candidates] BT 5704 Extended Essay (Subject area will be governed by research project) (10 credit points) In addition to lectures, the above courses will include practical training in gene cloning and computer modelling, assessed presentations and three major essay assignments. Throughout the programme, students will be given further instruction in aspects of laboratory safety and will attend sessions to improve their computing skills. The course will also include contributions from leading scientific academics and tutorials from senior members of the UK bio-business community. The students will also be given the opportunity to attend employability classes and careers workshops. Assessment: By course work, by written examinations, or by a combination of these, as prescribed for each course. All candidates shall attend an oral examination, and MSc candidates shall be required to submit a thesis on their project. The degree of MSc shall not be awarded to a candidate who fails to achieve a CAS mark of 9 or above in BT 5702S, irrespective of their performance in other courses: such candidates may be awarded a Postgraduate Diploma if they have achieved the appropriate number of credits for that award. YröÿO W í ’�¥¦øïøïøïøæøïøÝhïVfh,óaJh5K>*OJQJh5K6�OJQJh5KOJQJ XYõöN O   ¢ £ ì í  6 q Ú b’¿ÀÔíàààààààààààààÔÔÔÔÔÔÔàÇ  Æ0d6ÿgd5K Æ„d6ÿgd5K Æ0d6ÿgd5K$ Æ 0D%Âd6ÿa$gd5KÔÕ†Ï-.78fª«¬éGHõö‘’¥¦òÝÐÁÁÁÁÁÁÁÁÁд´´´´´¯gdïVf Æ*d6ÿgd5K Æ 9r „d6ÿgd5K Æ„d6ÿgd5K Æ„„„„|üd6ÿ^„„`„|ügd5K Æ0d6ÿgd5K21�h:pË4°‚. °ÆA!° "° #� $� %°°Ä°Ä �Äj ˜žžžžžž666666666vvvvvvvvv66666>666666666666666666666666666¨6666666666¸66666666666hH66666666666666666666666666666666666666666666666666666666666666666°62ÀÐàð 0@P`p€�ÀÐàð2(Øè 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�ÀÐàð 0@P`p€�8XøV~ OJPJQJ_HmH nH sH tH N`ñÿN B~Normal$a$ CJOJPJQJ_HmH sH tH 8@8 B~ Heading 2$@&>*>@> B~ Heading 3$d8ÿ@&5�XX N»� Heading 6 ¤ð¤<@&5�CJOJPJQJ\�^JaJRR F2%� Heading 7 ¤ð¤<@&CJOJPJQJ^JaJXX ‰L� Heading 8 ¤ð¤<@&6�CJOJPJQJ]�^JaJDA òÿ¡D Default Paragraph FontRióÿ³R 0 Table Normalö4Ö l4Öaö (k ôÿÁ( 0No List Pþ¢ñP B~Heading 2 Char>*CJOJPJQJ^JaJPþ¢P B~Heading 3 Char5CJOJPJQJ^JaJ4@4 B~Header  Æ9r Fþ¢!F B~ Header CharCJOJPJQJ^JaJVþ¢1V N»�Heading 6 Char"5CJOJPJQJ\^JaJtH Pþ¢AP F2%�Heading 7 CharCJOJPJQJ^JaJtH VQRV ne Body Text 3$ Æ0d6ÿa$ 5�OJQJPþ¢aP neBody Text 3 Char5CJOJPJQJtH Vþ¢qV ‰L�Heading 8 Char"6CJOJPJQJ]^JaJtH PK!‚мú[Content_Types].xml¬‘ËjÃ0E÷…þƒÐ¶Ørº(¥ØÎ¢Iw},Òä±-j�„4 Éßwì¸Pº-t#bΙ{U®�ã “óTéU^h…d}㨫ôûî)»×*1Pƒ'¬ô “^××Wåî0)™¦Též9<“l�#¤Ü$yi}�å;À~@‡æ¶(îŒõÄHœñÄÐuù* D× zƒÈ/0ŠÇ° ðûù $€˜ X«Ç3aZ¢ÒÂà,°D0j~è3ß¶Îbãí~i>ƒØÍ3¿\`õ?ê/ç[ج¶Géâ\Ä!ý-ÛRk.“sþÔ»�..—·´aæ¿­?ÿÿPK!¥Ö§çÀ6 _rels/.rels„�ÏjÃ0 ‡ï…½ƒÑ}QÒÃ%v/¥�C/£}á(h"ÛëÛOÇ »„¤ï÷©=þ®‹ùá”ç šªÃâC?Ëháv=¿‚É…¤§%[xp†£{Ûµ_¼PÑ£<Í1¥H¶0•ˆÙO¼R®BdÑÉÒJEÛ4b$§‘q_טžà6LÓõR×7`®�¨Éÿ³Ã0ÌžOÁ¯,åEn7”Liäb¡¨/ãS½�¨eªÔе¸ùÖýÿÿPK!ky–ƒŠtheme/theme/themeManager.xml ÌM à @á}¡w�Ù7c»(Eb²Ë®»öCœAÇ ÒŸÛ×åãƒ7ÎßÕ›K Y,œ ŠeÍ.ˆ·ð|,§¨ÚHÅ,láÇæéxÉ´�ßIÈsQ}#Õ�…­µÝ Öµ+Õ!ï,Ý^¹$j=‹GWèÓ÷)âEë+& 8ýÿÿPK!–µ­â–Ptheme/theme/theme1.xmlìYOoÛ6¿Øw toc'vuŠØ±›-MÄn‡i‰–ØP¢@ÒI}Úã€úa‡Øm‡a[�Ø¥û4Ù:lЯ°GR’ÅX^’6ØŠ­>$ùãûÿ©«×îÇ !)OÚ^ýrÍC$ñy@“°íÝö/­yH*œ˜ñ„´½)‘Þµ�÷ß»Š×UDb‚`}"×qÛ‹”J×—–¤ÃX^æ)I`nÌEŒ¼Šp)øèÆli¹V[]Š1M<”àÈÞ�©OÐP“ô6râ=¯‰’zÀgb Ig…Áu��SÙebÖö€OÀ�†ä¾òÃRÁDÛ«™Ÿ·´qu ¯g‹˜Z°¶´®o~ÙºlAp°lxŠpT0­÷­+[}`j×ëõº½zAϰV–2ÍF­ÞÉi–@öqžv·Ö¬5\|‰þʜ̭N§Óle²X¢dsøµÚjcsÙÁ�Å7çð�Îf·»êà ÈâWçðý+­Õ†‹7 ˆÑä`­ÚïgÔ È˜³íJøÀ×j|†‚h(¢K³óD-еß㢠dXÑ©iJÆØ‡(îâx$(Ö ð:Á¥;ä˹!Í I_ÐTµ½S 1£÷êù÷¯ž?EÇž?øéøáÃã?ZBΪmœ„åU/¿ýìÏÇ£?ž~óòÑÕxYÆÿúÃ'¿üüy5Òg&΋/ŸüöìÉ‹¯>ýý»GðM�Geø�ÆD¢›äíó3Vq%'#q¾ÃÓòŠÍ$”8ÁšKýžŠôÍ)f™w9:ĵàå£ x}rÏx‰‰¢œw¢ØîrÎ:\TZaGó*™y8IÂjæbRÆíc|XÅ»‹Ç¿½I u3KGñnD1÷NIBÒsü€� íîRêØu—ú‚K>Vè.EL+M2¤#'šf‹¶i ~™Vé þvl³{u8«Òz‹ºHÈ Ì*„æ˜ñ:ž(W‘☕ ~«¨JÈÁTøe\O*ðtHG½€HYµæ–}KNßÁP±*ݾ˦±‹ŠTѼ�9/#·øA7ÂqZ…Ð$*c?�¢íqUßån†èwðNºû%Ž»O¯·ièˆ4 =3Ú—Pª� ÓäïÊ1£P�m \\9†øâëÇ‘õ¶âMØ“ª2aûDù]„;Yt»\ôí¯¹[x’ìóù�ç]É}Wr½ÿ|É]”Ïg-´³Ú eW÷ ¶)6-r¼°CSÆjÊÈ išd ûDЇA½ÎœIqbJ#xÌ꺃 6k�àê#ª¢A„Sh°ëž&ÊŒt(QÊ%ìÌp%m�‡&]ÙcaSl=�XíòÀ¯èáü\P�1»MhŸ9£Mà¬ÌV®dDAí×aV×B�™[݈fJ�íP|8¯ Ö„AÛV^…ó¹f ÌH ín÷ÞÜ-Æ é"á€d>ÒzÏû¨nœ”ÇŠ¹ €Ø©ð‘>ä�bµ·–&ûÜÎâ¤2»Æv¹÷ÞÄKyϼ¤óöD:²¤œœ,AGm¯Õ\nzÈÇiÛÙã¼.uχYC¾6ìOMf“å3o¶rÅÜ$¨Ã5…µûœÂNH…T[XF64ÌT,Ñœ¬üËM0ëE)`#ý5¤XYƒ`ø×¤;º®%ã1ñUÙÙ¥m;ûš•R>QD ¢à�ØDìcp¿UÐ' ®&LEÐ/p�¦­m¦Üâœ%]ùöÊàì8fi„³r«S4Ïd 7y\È`ÞJâ�n•²åίŠIù R¥Æÿ3Uô~7+�ö€׸#�¯m� q¨BiDý¾€ÆÁÔˆ¸‹…i*¸L6ÿ9ÔÿmÎY&­áÀ§öiˆ…ýHE‚�=(K&úN!VÏö.K’e„LD•Ä•©{D 긪÷vEꦚdeÀàNÆŸûžeÐ(ÔMN9ßœRì½6þéÎÇ&3(åÖaÓÐäö/D¬ØUíz³<ß{ËŠè‰Y›Õȳ˜•¶‚V–ö¯)Â9·Z[±æ4^næÂ�ç5†Á¢!Já¾é?°ÿQá3ûeBo¨C¾µÁ‡M ¢ú’m<�.�vp�“´Á¤IYÓf­“¶Z¾Y_p§[ð=al-ÙYü}NcÍ™ËÎÉÅ‹4vfaÇÖvl¡©Á³'S†ÆùAÆ8Æ|Ò*uâ£{àè-¸ßŸ0%M0Á7%�¡õ˜<€ä·ÍÒ�¿ÿÿPK! Ñ�Ÿ¶'theme/theme/_rels/themeManager.xml.rels„�M Â0„÷‚wooÓº‘&݈ЭÔ„ä5 6?$Qìí ®,.‡a¾™i»—�Éc2Þ1hª:é•qšÁm¸ìŽ@RN‰Ù;d°`‚Žo7íg‘K(M&$R(.1˜r'J“œÐŠTù€®8£�Vä"£¦AÈ»ÐH÷u} ñ›|Å$½b{Õ–Pšÿ³ý8‰g/]þQAsÙ…(¢ÆÌà#›ªLÊ[ººÄßÿÿPK-!‚мú[Content_Types].xmlPK-!¥Ö§çÀ6 +_rels/.relsPK-!ky–ƒŠtheme/theme/themeManager.xmlPK-!–µ­â–PÑtheme/theme/theme1.xmlPK-! Ñ�Ÿ¶'› theme/theme/_rels/themeManager.xml.relsPK]– ¦ ÿÿÿÿ¦ Ô¦ ð8ð@ñÿÿÿ€€€÷ð’ðð0ð( ð ððB ðS ð¿Ëÿ ?ðÿÿ21‰œáá 31‰œÕá 41‰Üàá 51‰ßá 61‰ÜØá ÖÖ  H ¨ ØØ  T ¨ B*€urn:schemas-microsoft-com:office:smarttags€country-region€9*€urn:schemas-microsoft-com:office:smarttags€place€>*€urn:schemas-microsoft-com:office:smarttags €PersonName€ @^ù/45;GL¨ ¨ ¨ ¨ -å*. ka,!*#])#b $F2%K'˜)Ë45K‰LâAaneïVfQ=g‘ n }n„ póssB~Ë(†¼q‰øt�†�F3™†- ¶M¥n¦Uhªt¯Y²ÊR¶†+¸N»¾ À)ÓÇCÕ²\ã3tçñèÚ9ë,ó}%ù¦ ¨ ÿ@¦ `@ÿÿUnknownÿÿÿÿÿÿÿÿÿÿÿÿG�ï*àAxÀ ÿTimes New Roman5�€Symbol3.� ÿ*àCxÀ ÿArial7.�ï { @ŸCalibriY� CG TimesTimes New RomanA�ï ë BŸCambria Math"qˆðÐh3-é3-é � � � !ð  ´´��r0    2ƒqðüýHX ðÿ$PäÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿB~2!xx ÿÿRobertRobertþÿà…ŸòùOh«‘+'³Ù0 pxˆ˜ ¨´ Ô à ìøäRobertNormalRobert2Microsoft Office Word@@êð©3MË@êð©3MË � þÿÕÍÕœ.“—+,ù®0è hp|„Œ” œ¤¬´ ¼ Éä    Title þÿÿÿþÿÿÿ !"#$%&þÿÿÿ()*+,-.þÿÿÿýÿÿÿ1þÿÿÿþÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿRoot Entryÿÿÿÿÿÿÿÿ ÀF0V<½3MË3€1TableÿÿÿÿÿÿÿÿÆWordDocumentÿÿÿÿÿÿÿÿ4SummaryInformation(ÿÿÿÿDocumentSummaryInformation8ÿÿÿÿÿÿÿÿÿÿÿÿ'CompObjÿÿÿÿÿÿÿÿÿÿÿÿyÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿÿþÿ ÿÿÿÿ ÀF'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.8ô9²q